Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Stephen Waldo

Concepts (419)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
77
2025
543
17.990
Why?
Coronary Artery Disease
45
2025
741
10.360
Why?
United States Department of Veterans Affairs
33
2025
768
5.560
Why?
Coronary Angiography
31
2025
323
3.540
Why?
Peripheral Arterial Disease
25
2020
503
3.190
Why?
Myocardial Infarction
29
2025
1209
3.150
Why?
Endovascular Procedures
18
2020
384
2.950
Why?
Femoral Artery
13
2022
190
2.660
Why?
Acute Coronary Syndrome
8
2025
293
2.630
Why?
Treatment Outcome
91
2025
11695
2.550
Why?
Veterans
18
2025
1603
2.550
Why?
Vascular Calcification
9
2022
110
2.320
Why?
Veterans Health
7
2025
189
2.230
Why?
Stents
21
2019
556
2.170
Why?
ST Elevation Myocardial Infarction
6
2022
63
2.080
Why?
Popliteal Artery
11
2020
62
2.070
Why?
Atherectomy
11
2022
37
1.910
Why?
Myocardial Ischemia
6
2025
285
1.900
Why?
Risk Factors
70
2025
10792
1.870
Why?
Coronary Artery Bypass
8
2025
269
1.870
Why?
Registries
28
2023
2385
1.830
Why?
United States
64
2026
15988
1.750
Why?
Ischemia
11
2020
421
1.720
Why?
Atherectomy, Coronary
5
2022
10
1.660
Why?
Time Factors
52
2025
7183
1.660
Why?
Risk Assessment
29
2025
3676
1.620
Why?
Aged
89
2026
25947
1.610
Why?
Platelet Aggregation Inhibitors
8
2025
497
1.540
Why?
Radial Artery
7
2022
70
1.520
Why?
Lower Extremity
4
2018
438
1.500
Why?
Angioplasty, Balloon, Coronary
6
2017
158
1.490
Why?
Time-to-Treatment
5
2024
245
1.470
Why?
Hospitals, Veterans
5
2025
259
1.360
Why?
Middle Aged
82
2025
35928
1.340
Why?
Cardiovascular Agents
7
2023
164
1.300
Why?
Humans
160
2026
144957
1.300
Why?
Non-ST Elevated Myocardial Infarction
3
2020
25
1.250
Why?
Biological Products
2
2023
252
1.220
Why?
Hospital Mortality
13
2025
1031
1.210
Why?
Male
103
2026
72406
1.170
Why?
Coronary Restenosis
4
2017
22
1.160
Why?
Coronary Vessels
7
2025
251
1.150
Why?
Angioplasty, Balloon
9
2020
94
1.130
Why?
Female
97
2026
78376
1.060
Why?
Myocardial Revascularization
3
2019
85
1.040
Why?
Access to Information
2
2019
48
1.030
Why?
Retrospective Studies
54
2026
17101
1.020
Why?
Catheterization, Peripheral
2
2019
119
0.990
Why?
Stroke Volume
4
2026
651
0.950
Why?
Surgical Procedures, Operative
3
2025
271
0.920
Why?
Angina, Stable
3
2022
18
0.900
Why?
Exercise Test
3
2025
634
0.900
Why?
Patient Readmission
9
2025
759
0.880
Why?
Eligibility Determination
1
2025
68
0.870
Why?
Coated Materials, Biocompatible
6
2020
65
0.850
Why?
Natural Language Processing
1
2025
103
0.840
Why?
Quality Improvement
5
2025
1291
0.820
Why?
Delivery of Health Care, Integrated
2
2025
299
0.810
Why?
Quality of Health Care
3
2025
693
0.810
Why?
Cardiology
4
2022
353
0.810
Why?
Myocardial Reperfusion
2
2013
59
0.800
Why?
Community Health Services
1
2025
234
0.780
Why?
Cardiac Catheterization
5
2025
560
0.770
Why?
Vascular Patency
14
2020
121
0.760
Why?
Ventricular Function, Left
3
2021
541
0.750
Why?
Chickens
1
2023
191
0.750
Why?
Coronary Thrombosis
4
2015
25
0.720
Why?
Heart Arrest
3
2017
407
0.710
Why?
Vascular Access Devices
5
2020
30
0.710
Why?
Elective Surgical Procedures
2
2020
201
0.710
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2023
439
0.700
Why?
Psoriasis
1
2023
112
0.700
Why?
California
18
2019
475
0.690
Why?
Healthcare Disparities
3
2024
728
0.690
Why?
Anemia
2
2022
188
0.670
Why?
Practice Patterns, Physicians'
7
2025
1358
0.670
Why?
Coronary Occlusion
2
2023
20
0.670
Why?
Aged, 80 and over
23
2025
8279
0.660
Why?
Heart Failure, Systolic
1
2021
27
0.660
Why?
Patient Selection
1
2025
719
0.660
Why?
Drug-Eluting Stents
6
2017
88
0.620
Why?
Hospitals, Community
1
2020
65
0.620
Why?
Hemorrhage
5
2022
809
0.610
Why?
Assisted Circulation
1
2019
26
0.610
Why?
Paclitaxel
2
2019
256
0.610
Why?
Electronic Health Records
3
2025
1177
0.600
Why?
Hemostatic Techniques
1
2020
51
0.600
Why?
Cardiovascular Diseases
4
2025
2171
0.600
Why?
Embolic Protection Devices
1
2019
12
0.590
Why?
Quality Indicators, Health Care
4
2025
335
0.580
Why?
Saphenous Vein
1
2019
37
0.580
Why?
Intra-Aortic Balloon Pumping
1
2019
19
0.580
Why?
Graft Occlusion, Vascular
1
2019
42
0.580
Why?
Postoperative Hemorrhage
1
2020
104
0.570
Why?
Heart Failure
7
2026
2323
0.570
Why?
Databases, Factual
11
2025
1486
0.560
Why?
Postoperative Complications
5
2025
2920
0.560
Why?
Fibrinolytic Agents
2
2018
292
0.560
Why?
Cardiac Surgical Procedures
2
2022
609
0.560
Why?
Electrocardiography
4
2015
663
0.550
Why?
Arterial Occlusive Diseases
1
2018
90
0.540
Why?
Arm
1
2018
110
0.530
Why?
Odds Ratio
8
2021
1077
0.530
Why?
Peripheral Vascular Diseases
1
2018
104
0.530
Why?
Thromboembolism
1
2018
125
0.520
Why?
Cerebrovascular Disorders
1
2018
103
0.510
Why?
Kaplan-Meier Estimate
12
2020
966
0.510
Why?
Limb Salvage
7
2019
70
0.510
Why?
Propensity Score
6
2024
367
0.510
Why?
Renal Artery Obstruction
1
2017
29
0.500
Why?
Embolism
1
2017
48
0.500
Why?
Renal Artery
1
2017
43
0.490
Why?
Aspirin
2
2019
400
0.490
Why?
Research Report
1
2017
87
0.490
Why?
Contrast Media
4
2025
488
0.490
Why?
Hospitals
4
2023
732
0.480
Why?
Transcatheter Aortic Valve Replacement
3
2025
152
0.470
Why?
Catheterization
3
2021
183
0.470
Why?
Coronary Stenosis
5
2020
38
0.450
Why?
Iliac Artery
4
2019
55
0.440
Why?
Hospitalization
4
2025
2434
0.430
Why?
Disclosure
1
2015
85
0.430
Why?
Hypertension, Pulmonary
5
2025
1980
0.420
Why?
Risk Reduction Behavior
1
2016
226
0.420
Why?
Cell Separation
1
2015
307
0.410
Why?
Survival Rate
7
2026
2092
0.410
Why?
Atherosclerosis
3
2019
409
0.400
Why?
Thrombectomy
2
2014
78
0.400
Why?
Cohort Studies
10
2023
5965
0.400
Why?
Depressive Disorder
1
2017
387
0.400
Why?
Cardiologists
2
2025
47
0.380
Why?
Vascular Surgical Procedures
1
2016
340
0.380
Why?
Disease Management
1
2017
647
0.370
Why?
Predictive Value of Tests
9
2025
2118
0.370
Why?
Acute Kidney Injury
5
2025
866
0.370
Why?
Incidence
8
2025
2883
0.360
Why?
Peer Review
2
2025
44
0.360
Why?
HIV
1
2013
250
0.360
Why?
Logistic Models
6
2017
2119
0.350
Why?
Intermittent Claudication
3
2017
121
0.350
Why?
Attitude of Health Personnel
1
2019
1186
0.340
Why?
Hypothermia
1
2011
52
0.330
Why?
Hemodynamics
5
2026
1121
0.330
Why?
Out-of-Hospital Cardiac Arrest
2
2024
124
0.320
Why?
Cause of Death
3
2023
472
0.320
Why?
Stroke
7
2025
1258
0.320
Why?
Severity of Illness Index
8
2025
2925
0.310
Why?
Aortic Valve Stenosis
2
2025
253
0.300
Why?
Constriction, Pathologic
9
2020
248
0.290
Why?
Mentoring
2
2023
166
0.290
Why?
Proportional Hazards Models
9
2023
1325
0.290
Why?
Peptide Fragments
2
2015
699
0.290
Why?
Chi-Square Distribution
4
2018
529
0.290
Why?
Mortality
3
2020
376
0.290
Why?
Endothelial Cells
1
2015
870
0.280
Why?
Punctures
2
2019
40
0.280
Why?
Angiography
6
2020
208
0.280
Why?
Laser Therapy
2
2019
135
0.270
Why?
Natriuretic Peptide, Brain
1
2008
111
0.260
Why?
Carotid Stenosis
2
2018
102
0.250
Why?
Myocardial Perfusion Imaging
2
2019
49
0.250
Why?
Cardiac Output, High
1
2026
1
0.240
Why?
Recurrence
9
2019
1135
0.240
Why?
Sex Factors
5
2025
2114
0.240
Why?
Follow-Up Studies
7
2026
5417
0.240
Why?
Emergency Medical Services
1
2013
696
0.240
Why?
Multivariate Analysis
5
2017
1540
0.230
Why?
Ventricular Dysfunction, Left
2
2021
392
0.230
Why?
HIV Infections
3
2023
3154
0.230
Why?
Macrophages
3
2008
1511
0.230
Why?
Purinergic P2Y Receptor Antagonists
2
2023
69
0.230
Why?
Acute Disease
3
2017
1031
0.230
Why?
Cytochrome P-450 CYP2C19
1
2025
26
0.220
Why?
Ultrasonography, Interventional
2
2025
160
0.220
Why?
Patient Discharge
3
2022
983
0.220
Why?
Peer Review, Health Care
1
2025
4
0.220
Why?
Renal Insufficiency, Chronic
2
2023
653
0.220
Why?
Chest Pain
3
2022
100
0.220
Why?
Chemokine CXCL12
1
2025
89
0.220
Why?
Tomography, Optical Coherence
2
2025
271
0.210
Why?
Travel
1
2025
136
0.210
Why?
Comorbidity
5
2020
1660
0.210
Why?
Pancreas
2
2004
342
0.210
Why?
Prosthesis Failure
2
2016
128
0.200
Why?
Health Services Accessibility
2
2025
1099
0.200
Why?
Hypertension, Portal
1
2024
66
0.200
Why?
Hypothermia, Induced
1
2024
96
0.200
Why?
Coronary Circulation
2
2014
136
0.190
Why?
Fractional Flow Reserve, Myocardial
2
2020
9
0.190
Why?
Biological Therapy
1
2023
28
0.190
Why?
Heart Valve Prosthesis Implantation
1
2025
197
0.190
Why?
Cross-Sectional Studies
6
2022
5872
0.190
Why?
New York
3
2017
127
0.190
Why?
Work Engagement
1
2022
14
0.180
Why?
Prognosis
6
2021
4293
0.180
Why?
Chronic Disease
5
2023
1813
0.180
Why?
Leukocytes
1
2003
295
0.180
Why?
Technology Transfer
1
2021
9
0.170
Why?
Clinical Decision-Making
1
2025
359
0.170
Why?
Social Class
1
2023
268
0.170
Why?
Critical Illness
8
2020
892
0.170
Why?
Shock, Cardiogenic
2
2021
64
0.160
Why?
Angina Pectoris
1
2020
75
0.160
Why?
Aftercare
1
2022
224
0.160
Why?
Mandatory Reporting
2
2017
47
0.160
Why?
Anticoagulants
2
2016
724
0.160
Why?
Thrombocytopenia
1
2022
205
0.160
Why?
Massachusetts
2
2017
180
0.150
Why?
Patient Care Team
1
2025
689
0.150
Why?
Genome-Wide Association Study
2
2025
1407
0.150
Why?
Delivery of Health Care
2
2023
947
0.150
Why?
Echocardiography, Stress
1
2019
29
0.150
Why?
Vascular Resistance
1
2020
367
0.150
Why?
Referral and Consultation
1
2025
853
0.150
Why?
Health Facilities
1
2019
85
0.150
Why?
Intraoperative Period
1
2019
69
0.140
Why?
Ambulatory Surgical Procedures
1
2019
80
0.140
Why?
Fluid Therapy
1
2020
147
0.140
Why?
Heart
1
2022
636
0.140
Why?
Centralized Hospital Services
1
2018
6
0.140
Why?
Socioeconomic Factors
1
2023
1327
0.140
Why?
Thrombosis
1
2022
393
0.140
Why?
Colorado
8
2019
4564
0.140
Why?
Angioplasty, Balloon, Laser-Assisted
1
2017
1
0.140
Why?
Secondary Prevention
1
2019
255
0.140
Why?
Biomarkers
4
2017
4275
0.140
Why?
Pregnancy-Associated Plasma Protein-A
1
2017
14
0.130
Why?
Angioplasty
1
2018
50
0.130
Why?
Perception
1
2021
377
0.130
Why?
Disease-Free Survival
5
2017
769
0.130
Why?
Cardiac Catheters
1
2017
16
0.130
Why?
Transportation of Patients
1
2018
68
0.130
Why?
Perioperative Care
1
2020
231
0.130
Why?
Rosuvastatin Calcium
1
2017
21
0.130
Why?
Diabetes Mellitus, Type 2
2
2023
2584
0.130
Why?
Macrophage Colony-Stimulating Factor
2
2008
19
0.130
Why?
ADAMTS13 Protein
1
2017
7
0.130
Why?
Pulmonary Artery
1
2023
1134
0.130
Why?
Algorithms
2
2017
1839
0.130
Why?
Thrombotic Microangiopathies
1
2017
19
0.130
Why?
Neck
1
2017
108
0.130
Why?
Computer Simulation
1
2021
1026
0.130
Why?
Ankle Brachial Index
1
2017
41
0.130
Why?
Risk
2
2019
911
0.130
Why?
Suction
2
2014
33
0.120
Why?
Policy Making
1
2017
82
0.120
Why?
Reproducibility of Results
5
2025
3415
0.120
Why?
Clinical Competence
1
2025
1244
0.120
Why?
Flow Cytometry
2
2015
1173
0.120
Why?
Aortic Valve
1
2019
365
0.120
Why?
Health Services Needs and Demand
1
2018
280
0.120
Why?
Boston
1
2016
92
0.120
Why?
Academic Medical Centers
2
2016
548
0.120
Why?
Adult
7
2024
40506
0.120
Why?
Dyslipidemias
1
2017
182
0.110
Why?
Burnout, Professional
1
2022
484
0.110
Why?
Pandemics
2
2021
1695
0.110
Why?
Receptors, Cytoplasmic and Nuclear
2
2007
210
0.110
Why?
Cholesterol
2
2008
408
0.110
Why?
Contraindications
1
2014
91
0.110
Why?
Gene Expression Profiling
2
2015
1786
0.110
Why?
Aortic Diseases
1
2016
124
0.110
Why?
Antithrombins
1
2015
70
0.110
Why?
Collateral Circulation
1
2014
19
0.110
Why?
Models, Cardiovascular
1
2015
195
0.110
Why?
Prevalence
2
2019
2836
0.100
Why?
Heparin
1
2015
244
0.100
Why?
Observer Variation
3
2025
355
0.100
Why?
Prospective Studies
3
2020
7997
0.100
Why?
Incidental Findings
1
2013
80
0.100
Why?
Diabetes Mellitus
2
2018
1098
0.090
Why?
Resuscitation
1
2015
302
0.090
Why?
Primary Prevention
1
2014
220
0.090
Why?
Smoking Cessation
1
2016
439
0.090
Why?
Coronary Disease
1
2014
386
0.090
Why?
Trazodone
1
2011
2
0.090
Why?
Antimanic Agents
1
2011
19
0.090
Why?
Glucagon-Like Peptide-1 Receptor
2
2023
88
0.090
Why?
Lithium
1
2011
42
0.090
Why?
Triazines
1
2011
49
0.090
Why?
Laboratories
2
2022
109
0.080
Why?
American Heart Association
2
2022
350
0.080
Why?
Prosthesis Design
3
2017
357
0.080
Why?
Decision Support Techniques
1
2014
456
0.080
Why?
Benzodiazepines
1
2011
168
0.080
Why?
Age Factors
4
2019
3335
0.070
Why?
Lipoproteins, LDL
2
2007
119
0.070
Why?
Cell Differentiation
2
2008
2050
0.070
Why?
Anticonvulsants
1
2011
242
0.070
Why?
Bipolar Disorder
1
2011
280
0.070
Why?
MicroRNAs
1
2015
701
0.070
Why?
Depression
1
2018
1559
0.070
Why?
Pinocytosis
1
2007
6
0.070
Why?
Ultrasonography, Doppler, Duplex
2
2017
40
0.070
Why?
Monocytes
2
2007
538
0.070
Why?
Area Under Curve
1
2008
331
0.070
Why?
Seizures
1
2011
477
0.060
Why?
Animals
4
2025
38109
0.060
Why?
Fluorescent Antibody Technique
1
2008
370
0.060
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2008
161
0.060
Why?
Adrenergic beta-Antagonists
2
2019
250
0.060
Why?
Drug Overdose
1
2011
370
0.060
Why?
Phenotype
2
2021
3164
0.060
Why?
ROC Curve
1
2008
615
0.060
Why?
Polymorphism, Single Nucleotide
2
2025
2147
0.060
Why?
Inflammation
3
2008
2880
0.060
Why?
Equipment Design
2
2018
530
0.060
Why?
Shock
2
2004
108
0.060
Why?
Polymerase Chain Reaction
1
2008
1054
0.050
Why?
Program Evaluation
2
2019
949
0.050
Why?
Health Plan Implementation
1
2025
136
0.050
Why?
Ventricular Fibrillation
1
2024
64
0.050
Why?
Survival Analysis
2
2020
1385
0.050
Why?
Lipid Metabolism
1
2008
528
0.050
Why?
Trypsin
1
2004
76
0.050
Why?
Exercise
1
2016
2201
0.050
Why?
Amylases
1
2003
18
0.050
Why?
Matrix Metalloproteinase 9
1
2004
132
0.050
Why?
Chymotrypsin
1
2003
23
0.050
Why?
Ezetimibe
1
2023
24
0.050
Why?
Length of Stay
2
2019
1337
0.050
Why?
Tissue Distribution
1
2003
334
0.050
Why?
Tachycardia, Ventricular
1
2024
181
0.050
Why?
Drug Therapy, Combination
2
2016
1048
0.050
Why?
Hypoglycemic Agents
2
2023
1389
0.050
Why?
Polymorphism, Genetic
1
2025
612
0.050
Why?
Glucagon-Like Peptide 1
1
2023
146
0.050
Why?
Pancreatitis
1
2003
145
0.050
Why?
Rats, Wistar
1
2003
451
0.050
Why?
Personnel Turnover
1
2022
42
0.040
Why?
Practice Guidelines as Topic
2
2020
1563
0.040
Why?
Liver Cirrhosis
1
2024
288
0.040
Why?
Cell Death
1
2003
383
0.040
Why?
Cholesterol, LDL
1
2023
358
0.040
Why?
Reperfusion Injury
1
2004
300
0.040
Why?
Troponin
1
2021
49
0.040
Why?
Neutrophils
2
2004
1134
0.040
Why?
Consensus
1
2023
489
0.040
Why?
Organizational Culture
1
2022
162
0.040
Why?
Disease Progression
2
2019
2852
0.040
Why?
Systole
1
2021
178
0.040
Why?
Inpatients
1
2025
546
0.040
Why?
Cells, Cultured
1
2008
4155
0.040
Why?
Ambulatory Care
1
2025
603
0.040
Why?
Genotype
1
2025
1835
0.040
Why?
Free Radical Scavengers
1
2020
82
0.040
Why?
Cytokines
1
2008
2065
0.040
Why?
Sodium Bicarbonate
1
2020
47
0.040
Why?
DNA-Binding Proteins
1
2007
1500
0.040
Why?
Job Satisfaction
1
2022
240
0.040
Why?
Sodium
1
2020
197
0.040
Why?
Acetylcysteine
1
2020
139
0.040
Why?
Hospitals, High-Volume
1
2019
49
0.040
Why?
Exercise Tolerance
1
2021
283
0.040
Why?
Cost Savings
1
2019
86
0.040
Why?
Endocrinologists
1
2018
11
0.040
Why?
Angiotensin Receptor Antagonists
1
2019
114
0.040
Why?
Drug Utilization
1
2019
167
0.040
Why?
Retreatment
1
2018
77
0.040
Why?
Hypertension
2
2018
1264
0.040
Why?
Comparative Effectiveness Research
1
2019
170
0.030
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2019
222
0.030
Why?
Rats
2
2004
5614
0.030
Why?
Singapore
1
2017
27
0.030
Why?
Republic of Korea
1
2017
42
0.030
Why?
Transcription Factors
1
2006
1742
0.030
Why?
Angina, Unstable
1
2017
82
0.030
Why?
Purpura, Thrombotic Thrombocytopenic
1
2017
14
0.030
Why?
Combined Modality Therapy
1
2020
1268
0.030
Why?
New Jersey
1
2016
16
0.030
Why?
Michigan
1
2016
136
0.030
Why?
Glomerular Filtration Rate
1
2020
760
0.030
Why?
Aortography
1
2016
52
0.030
Why?
Platelet Aggregation
1
2016
105
0.030
Why?
Postoperative Care
1
2017
288
0.030
Why?
Glucose
1
2020
1049
0.030
Why?
Guideline Adherence
1
2019
589
0.030
Why?
Linear Models
1
2017
854
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1721
0.030
Why?
Drug Prescriptions
1
2017
285
0.030
Why?
Hirudins
1
2015
51
0.030
Why?
Blood Transfusion
1
2017
405
0.030
Why?
Blood Coagulation
1
2016
268
0.030
Why?
Protective Factors
1
2014
99
0.030
Why?
Clinical Trials as Topic
1
2019
1054
0.030
Why?
Genetic Predisposition to Disease
1
2022
2365
0.020
Why?
Health Policy
1
2016
401
0.020
Why?
Blood Flow Velocity
1
2014
413
0.020
Why?
Emergencies
1
2013
176
0.020
Why?
Lipids
1
2017
710
0.020
Why?
Recombinant Proteins
1
2015
1371
0.020
Why?
Cost-Benefit Analysis
1
2014
636
0.020
Why?
Health Care Costs
1
2014
427
0.020
Why?
Kidney Failure, Chronic
1
2017
598
0.020
Why?
Longitudinal Studies
1
2018
2947
0.020
Why?
Models, Biological
1
2017
1822
0.020
Why?
Surveys and Questionnaires
1
2022
6053
0.020
Why?
Medicare
1
2014
887
0.020
Why?
Clofibrate
1
2007
3
0.020
Why?
Orphan Nuclear Receptors
1
2007
14
0.020
Why?
Hydrocarbons, Fluorinated
1
2007
8
0.020
Why?
Peroxisome Proliferator-Activated Receptors
1
2007
17
0.020
Why?
Liver X Receptors
1
2007
30
0.020
Why?
beta-Cyclodextrins
1
2007
32
0.020
Why?
Mice
1
2025
18365
0.020
Why?
Fluorocarbons
1
2007
143
0.010
Why?
Down-Regulation
1
2007
627
0.010
Why?
Physicians
1
2013
940
0.010
Why?
Mesenteric Arteries
1
2004
18
0.010
Why?
Jejunum
1
2004
35
0.010
Why?
Interleukin-10
1
2006
310
0.010
Why?
Telemedicine
1
2013
948
0.010
Why?
Gelatin
1
2004
56
0.010
Why?
Peroxidase
1
2004
168
0.010
Why?
Sulfonamides
1
2007
581
0.010
Why?
Microscopy, Fluorescence
1
2004
418
0.010
Why?
Enzyme Activation
1
2004
768
0.010
Why?
Blotting, Western
1
2004
1187
0.010
Why?
Rats, Sprague-Dawley
1
2004
2540
0.010
Why?
Waldo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)